drugset / Trial / NCT01304329

Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin

NCT01304329

Phase 1 Completed 18 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the study is to investigate the drug-drug interaction potential between BI 10773 and simvastatin.

Timeline

Start
2011-02
Primary completion
2011-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule Oral
Subject Simvastatin Small molecule Oral

Indications

No indication recorded.